EUROIMMUN Medizinische Labordiagnostika
EUROIMMUN is a company dedicated to producing test and automation systems for medical laboratory diagnostics. They focus on innovative solutions in the field of immunology and diagnostics, with a mission to improve health through advanced laboratory testing. The company values diversity, quality, and continuous development, offering a wide range of products and services including autoimmunodiagnostics, infectious disease diagnostics, allergology, molecular genetics, automation, and more. They are committed to high-quality standards, employee development, and global presence with offices and partnerships worldwide.
Industries
Nr. of Employees
large (251-1000)
EUROIMMUN Medizinische Labordiagnostika
Patents
Method of detecting presences of different antinuclear antibody fluorescence pattern types without counterstaining and apparatus therefor
US-12209965-B2
View Details
Method of detecting presences of different antinuclear antibody fluorescence pattern types without counterstaining and apparatus therefor
US-12209965-B2
View DetailsProducts
Automated laboratory analyzers and random-access automation systems
Automated instruments for processing immunoassays and chemiluminescence assays in clinical laboratories, designed for high throughput and flexible workflow integration.
Immunoassay test kits (ELISA, immunoblot, IIFT, chemiluminescence)
In vitro diagnostic kits and reagents for detection of antibodies and antigens across multiple diagnostic indications including autoimmunity, allergy and infectious disease.
Molecular diagnostic kits and genotyping assays
PCR-based assays and genotyping tests for molecular diagnostics, including applications for therapy stratification and pathogen detection.
Microarray and biochip assay products
Multiplexed microarray-based substrates and assays for simultaneous detection of multiple analytes.
Automated laboratory analyzers and random-access automation systems
Automated instruments for processing immunoassays and chemiluminescence assays in clinical laboratories, designed for high throughput and flexible workflow integration.
Immunoassay test kits (ELISA, immunoblot, IIFT, chemiluminescence)
In vitro diagnostic kits and reagents for detection of antibodies and antigens across multiple diagnostic indications including autoimmunity, allergy and infectious disease.
Molecular diagnostic kits and genotyping assays
PCR-based assays and genotyping tests for molecular diagnostics, including applications for therapy stratification and pathogen detection.
Microarray and biochip assay products
Multiplexed microarray-based substrates and assays for simultaneous detection of multiple analytes.
Services
In-person and practical training courses for customers on use of diagnostic assays and instruments, including microscopy and method-specific workshops.
Support services for analyzer hardware and diagnostic software, including product training for field staff and helpdesk assistance.
Local market representation, distributor management and field sales to support product commercialization and customer acquisition.
In-person and practical training courses for customers on use of diagnostic assays and instruments, including microscopy and method-specific workshops.
Support services for analyzer hardware and diagnostic software, including product training for field staff and helpdesk assistance.
Local market representation, distributor management and field sales to support product commercialization and customer acquisition.
Expertise Areas
- Clinical diagnostics
- Laboratory automation
- Assay development and validation
- Molecular diagnostics and genotyping
Key Technologies
- ELISA
- Chemiluminescence immunoassays
- Indirect immunofluorescence (IIFT)
- Immunoblot
News & Updates
EU-Commission approves Alzheimer's medication; APOE genotyping is crucial for access to therapy.
Advancing endocrinology diagnostics with scientifically proven quality test systems.
Introduction of the IDS i20 device for chemiluminescence immunoassay automation.
The new ELISA test for anti-AChR antibodies shows high concordance with the RIA method.
Introduction of 23 new assays for the UNIQO 160 system.
Kununu Top Company 2022 and 2023
Recognition as a top employer on Kununu for two consecutive years.
EU-Commission approves Alzheimer's medication; APOE genotyping is crucial for access to therapy.
Advancing endocrinology diagnostics with scientifically proven quality test systems.
Introduction of the IDS i20 device for chemiluminescence immunoassay automation.
The new ELISA test for anti-AChR antibodies shows high concordance with the RIA method.
Introduction of 23 new assays for the UNIQO 160 system.
Kununu Top Company 2022 and 2023
Recognition as a top employer on Kununu for two consecutive years.